APEX-Agents category
AI Agents for Tariff and Trade Law Analysis
This page showcases APEX-Agents tasks that test whether AI agents can reason about tariff exposure, trade law constraints, IEEPA-related disputes, and supply-chain compliance risk.
Primary tasks
10 tasks with this category as their main focus.
-
TAC and its supplier executed the first draft of the Master Supply Agreement document (Template 1) as of April 1, 2025. President Trump announced additional tariffs on July 20, 2025. The supplier's raw materials come from Iraq. The supplier sends TAC notice that it intends to invoke the force majeure clause as a result of the tariffs. May the supplier do so under the terms of the agreement? Tell me your main findings by replying to me here.
Expected output: message_in_console -
TRIDENT AUTO CORPORATION (The "Plaintiff") has filed a claim challenging a 25% tariff that President Trump (the "Defendant") imposed on goods imported from China under the International Emergencies Economic Powers Act (IEEPA). The case is being heard by Judge Rudolph Contreras in the United States District Court for the District of Columbia. Will the Plaintiff succeed in challenging the tariff? Provide me with a yes or no answer and a single sentence explanation. Reply straight back here.
Expected output: message_in_console -
Review the two supply agreement templates, Master Supply Agreement Template 1.docx and Master Supply Agreement Template 4.pdf, along with the attached files (UCC §2-209 and Restatement (Second) of Contracts §89) to determine whether the supplier’s tariff-based request for a mid-term price increase would be a valid modification. Reply to me here with your assessment.
Expected output: message_in_console -
TRIDENT AUTO CORPORATION (The "Plaintiff") has filed a Complaint against United States President Donald Trump (the "Defendant") in the United States District Court for the District of Columbia challenging a 30% tariff that the Defendant imposed on imports for metals that the Plaintiff uses in manufacturing. The Plaintiff has claimed that the International Emergency Economic Powers Act ("IEEPA") does not grant the Defendant to impose tariffs. The Defendant has moved to transfer the action to the Court of International Trade. The case has been assigned to Judge Rudolph Contreras. Will the motion be granted? Give me a reply with a yes or no answer and a single sentence explanation.
Expected output: message_in_console -
Due to a riot occurring in response to an Executive Order that resulted in the closure of its factories, TAC sought relief from performance under the force majeure section of the Master Supply Agreement. Citing the attached case, Buyer asserts that TAC is not excused from performance. Is Buyer correct? Provide your response in here with the following: "Yes/No"; and brief explanation.
Expected output: message_in_console -
Can you take a look at the two Master Supply Agreement templates (Master Supply Agreement Template.pdf ("Template1"), Master Supply Agreement 2.pdf ("Template2"))? We’re considering them for Acme (the steel supplier) and we want a comparison. I need to know how each template deals with tariff‑related cost exposure, since Acme is importing steel from outside USMCA and the new tariffs are creating real financial pressure. Also, TAC is thinking about giving Acme a cash infusion secured by a lien on their receivables, but we’re worried about what happens if Acme goes bankrupt. Could you assess whether that financing structure would expose TAC to creditor claims, and which template gives TAC the most operational control? Please point to the clauses that support your analysis. Now, send me a clear text summary straight in here.
Expected output: message_in_console -
TRIDENT AUTO CORPORATION (The "Plaintiff") has filed a claim in the United States District Court for the District of Columbia against several federal government agencies (The "Defendants"). The Claim alleges that the Defendants have violated the Administrative Procedure Act (The "APA") by implementing several tariffs issued by Donald Trump under the International Emergencies Economic Powers Act ("IEEPA"). The claim is being heard in the United States District Court for the District of Columbia. The presiding Judge is Rudolph Contreras. Will the Plaintiffs succeed in their claim? Reply back to me with a Yes or No answer and a single sentence explanation.
Expected output: message_in_console -
TAC has just informed us that they expect a 20% drop in gross margin due to import tariffs. TAC has posted the information on their website as they have done in the past. Write me back a brief message, explaining whether this will trigger an additional 8K filing.
Expected output: message_in_console -
Using the 2024 ATR annual report, analyze the results of a 15% tariff on Aptar Group’s FY2024 net income. Assume the 15% applies only to Cost of Sales, exclusive of depreciation and amortization. Round all values to the nearest thousand. Use a 20.35% tax rate. Output just the pro-forma net income as a reply here.
Expected output: message_in_console -
Analyse market cost efficiency using the Cost Structure Score methodology for PureLife’s Vitamins strategy: - Calculate the Total Cost Structure Score for each market under the weighted methodology using the following components: Import Cost Score (35%), Distribution Cost Score (35%), and Total Cost Load Score (30%). - Show the country with the highest cumulative cost structure score and the country with the lowest cumulative cost structure score, with each entry showing the market name and corresponding score side by side (e.g., China – 3.81). Format percentages to 0.01%. Round all numbers and intermediate calculations to two decimals. Output the answer in here.
Expected output: message_in_console
Related tasks
1 tasks that also exercise this type of work as part of a broader assignment.
-
Given the US imposed tariffs on the import of pharmaceutical materials from Germany, India, China at the rates 10%, 15%, 20% respectively, determine the impact of tariffs as a percent increase in predicted total cost of drug materials for 2025 compared to the same without the tariffs. State both % increase in cost and the dollar amount of the total cost including tariffs. Assume the suppliers and location remain the same. Also, calculate the predicted total cost of drug materials for 2025 if the client switches to exclusively domestic suppliers, using the average of the average percent material cost increase reported by latest group of six expert witnesses. State this average % value in the output. Assume the data reported by expert witnesses is per year. You can use the predicted total cost of drug materials for 2025 without the tariffs as the baseline. Round final outputs to two decimal places, giving $ values in billions. Return back to me what you find, printing the values out here.
Expected output: message_in_console